Life Extension Spring Clearance Sale

Life Extension Magazine

Life Extension Magazine May 2009
Reports

How to Circumvent 17 Independent Heart Attack Risk Factors

By William Faloon
Oxidized LDL

HEART ATTACK RISK FACTOR #17: Oxidized LDL

Optimal Blood Level: Commercial blood tests are not yet available at affordable prices to measure oxidized LDL. Aging individuals should assume their endogenous antioxidant levels (superoxide dismutase, catalase, and glutathione) are being depleted and that the oxidation of their LDL (low-density lipoprotein) is progressively worsening.

The over-promotion of “statin” drugs has resulted in today’s cardiologists focusing on reducing their patient’s LDL and total cholesterol levels. Pharmaceutical company advertising makes it appear as if the only cause of atherosclerosis is excess LDL and cholesterol.

Beginning in 1979, however, researchers made discoveries indicating that the oxidation of LDL results in severe arterial damage. Thousands of studies now reveal how oxidized LDL contributes to the entire atherosclerotic process from start to finish.302

Drug options: Statin drugs help protect against LDL oxidation; however, by inhibiting coenzyme Q10 synthesis, they deprive the body of one of its most important protectors against LDL oxidation.

Nutrient options: Most Life Extension members take nutrients that have been shown to significantly reduce LDL oxidation such as gamma tocopherol,303,304 sesame lignans,305 and lycopene.306,307 A number of studies document the ability of ubiquinol CoQ10 to protect against LDL oxidation better than lycopene, alpha tocopherol, and other lipid-soluble antioxidants.308 Perhaps no other nutrient has demonstrated better anti-LDL oxidation effects than pomegranate. In a clinical study, human subjects taking pomegranate showed a remarkable 90% reduction in the LDL basal oxidative state.50 There are standardized pomegranate supplements that provide the active constiutuents shown to reduce LDL oxidation. The usual dose is 400-500 mg of these standardized pomegranate capsules a day. The suggested dose for ubiquinol to reduce LDL oxidation is 100-200 mg a day.

Dietary options: The term postprandial oxidative stress means the oxidation that occurs after ingesting a meal. The higher the calorie, sugar, and fat content of the meal, the greater the level of post-meal oxidative stress. Reduce calorie content and take antioxidant supplements with each meal. Some people also consume polyphenol-rich beverages such as green tea, red wine, or pomegranate juice with meals to reduce postprandial oxidative stress.50,203,242,309 Beware of the high sugar calories in red wine and pomegranate juice.

Hormone options: The hormones melatonin and DHEA confer significant protection against LDL oxidation. As these hormones decline with normal aging, LDL oxidation increases, as does heart attack and stroke risk. Aging humans can supplement with melatonin doses as low as 300 mcg all the way up to 10-20 mg. Women usually need only modest DHEA dosing (15-25 mg in the morning), whereas men usually need 50 mg of DHEA each morning and sometimes higher. A DHEA blood test enables one to restore their DHEA to the optimal youthful range of 500-640 mcg/dL for men and 250-380 mcg/dL for women. Those with hormone-sensitive cancers are often advised to avoid DHEA.

Virtually No One Should Be Having Heart Attacks Today!

A question that future medical historians may ask is why so many people kept having heart attacks and strokes when proven ways existed to detect and correct the known risk factors.

Based on decades of intensive scientific research, the underlying causes of heart attack and stroke are not a mystery. For reasons that relate to apathy and ignorance, along with drug company propaganda, the majority of aging humans are walking around with a time bomb (coronary atherosclerosis) ticking in their chests. Many are doing nothing to prevent heart attack, while others are making such partial efforts that they are only postponing the inevitable.

I spent an inordinate amount of time assembling the data to write this article because I am shocked that so many dedicated Life Extension members are failing to correct for all 17 of these proven vascular disease risk factors. Please remember, if you do almost everything right, but ignore even one of these 17 risk factors, you subject yourself to the horrific consequences of blockage of critical arteries that carry blood to your heart, brain, and kidneys.

It is my sincere desire to never again hear from a health-conscious person that they have been diagnosed with coronary artery occlusion. That’s why we have made comprehensive blood testing available at ultra-low prices.

With the data presented in this article, you can order low-cost blood tests, find out what your heart attack vulnerabilities are, and take immediate corrective actions. You should also make sure you know your blood pressure and take whatever steps are needed to keep it at 115/75 mmHg or lower (there are exceptions to this, such as those suffering from diabetic and certain kidney disorders).

To order a panel of comprehensive blood tests at the lowest prices of the year, call 1-800-208-3444 or log on to www.lef.org/blood. Please order these tests by June 1, 2009 to save more than 80% compared with what commercial labs charge.

To view the comprehensive blood test panels available to Foundation members, visit the Blood Test link above.

If you have any questions on the scientific content of this article, please call a Life Extension Health Advisor at 1-800-226-2370.

References

1. Proc Natl Acad Sci USA. 1990 Nov;87(22):8931-4.

2. Journal of Atheroscler Thromb. 2005;12(2):111-9.

3. Zhonghua Yi Xue Za Zhi. 2006 Sep 12;86(34):2399-403.

4. JAMA. 2000 Sep 13;284(10):1263-70.

5. Am J Cardiol. 2000 Dec 21;86(12A):46L-50L.

6. Arch Intern Med. 2000 Apr 24;160(8):1177-84.

7. J Am Acad Nurse Pract. 2004 Dec;16(12):526-34.

8. J Am Coll Cardiol. 1986 Dec;8(6):1245-55.

9. J Ethnopharmacol. 2002 Jan;79(1):81-7.

10. J Nutr Sci Vitaminol (Tokyo). 2005 Dec;51(6):413-8.

11. Yakugaku Zasshi. 2007 Feb;127(2):385-8.

12. Indian J Exp Biol. 2001 Aug;39(8):760-6.

13. R&D Laboratory, Arjuna Natural Extracts Ltd PBNO 126 Alwaya Cohin Karala India. Amlamax™ in management of dyslipidemia in humans. 2007.

14. R&D Laboratory, Arjuna Natural Extracts Ltd PBNO 126 Alwaya Cohin Karala India. Reduction of the risk of coronary heart disease (CHD) through a multi component targeting, including CRP-levels using Amlamax™ (AED-205) the standardized dry extract of Emblica officianalis Gaertn. (Indian gooseberry). 2007.

15. Br J Nutr. 2007 Jun;97(6):1187-95.

16. Yakugaku Zasshi. 2005 Jul;125(7):587-91.

17. Am J Ther. 2007 Mar-Apr;14(2):203-12.

18. Diabetes Care. 2006 May;29(5):976-81.

19. J Nutr. 2003 Mar;133(3):808-13.

20. Am J Clin Nutr. 1999 Oct;70(4):466-73.

21. J Nutr. 1989 Dec;119(12):1925-31.

22. Br J Nutr. 1996 Jul;76(1):63-73.

23. Am J Cardiol. 1997 Jan 1;79(1):34-7.

24. Am J Clin Nutr. 1997 Nov;66(5):1183-7.

25. Am J Clin Nutr. 2008 Oct;88(4):1167-75.

26. Arch Intern Med. 2003 Jun 23;163(12):1448-53.

27. J Nutr. 2003 Oct;133(10):3298S-302S.

28. J Nutr. 2003 Oct;133(10):3293S-7S.

29. Nutrition J. 2008 (submitted).(References continued on page 80)

30. Lipids Health Dis. 2005 May 25;4:12.

31. J Food Technol. 2005;3(4): 472-4.

32. Lipids Health Dis. 2008 Nov 13;7:44.

33. Atherosclerosis. 2009 Mar;203(1):206-13.

34. Nutr Rev. 2006 Feb;64(2 Pt 2):S27-S47.

35. J Am Coll Nutr. 2007 Oct;26(5):434-44.

36. Lipids Health Dis. 2007 Sep 19;6:22.

37. J Am Coll Cardiol. 2004 Jul 7;44(1):152-8.

38. JAMA. 2003 Jul 23;290(4):502-10.

39. Aging Male. 2002 Jun;5(2):98-102.

40. Int J Cardiol. 2005 May 11;101(1):105-10.

41. J Atheroscler Thromb. 1996;3(1):45-51.

42. J Clin Endocrinol Metab. 2000 Jul;85(7):2370-7.

43. J Steroid Biochem Mol Biol. 2005 Apr;94(5):461-7.

44. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):205-12.

45. Science. 1984 Sep 7;225(4666):1032-4.

46. www.niaspan.com/.

47. Coron Artery Dis. 1996 Apr;7(4):321-6.

48. Indian J Physiol Pharmacol. 2001 Jan;45(1):71-9.

49. Clin Biochem. 2006 Aug;39(8):821-5.

50. Clin Nutr. 2004 Jun;23(3):423-33.

51. Mol Cell Biol. 2004 Jun;24(12):5209-22.

52. Rom J Intern Med. 2007;45(1):17-27.

53. Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1112-8.

54. Biochem Biophys Res Commun. 2002 Sep 6;296(5):1051-7.

55. Diabetes Care. 1999 Jan;22(1):45-9.

56. Proc Natl Acad Sci USA. 1992 Dec 1;89(23):11533-7.

57. Drugs. 1999;58(Suppl 1):71-3.

58. Scand J Clin Lab Invest. 1997 Oct;57(6):521-7.

59. J Atheroscler Thromb. 2008 Jun;15(3):154-9.

60. Stroke. 2004 May;35(5):1073-8.

61. Endocr Pract. 2006 Jan-Feb;12(Suppl 1):56-9.

62. Nutrition. 2005 Jul-Aug;21(7-8):848-54.

63. J Am Diet Assoc. 2005 Jan;105(1):65-71.

64. Altern Med Rev. 2004 Mar;9(1):63-9.

65. Ann Nutr Metab. 1993;37(1):14-23.

66. West Afr J Med. 1990 Apr-Jun;9(2):108-15.

67. Afr J Trad CAM. 2006;3:74–7.

68. Afr J Trad CAM. 2006;3(4):94-101.

69. Diabetes Res Clin Pract. 1995 Jun;28(3):179-84.

70. Saudi Med J. 2000 Jan;21(1):45-50.

71. Ned Tijdschr Geneeskd. 2004 Jan 31;148(5):217-20.

72. Altern Med Rev. 2002 Jun;7(3):218-35.

73. Diabetes. 1997 Nov;46(11):1786-91.

74. J Nutr Sci Vitaminol (Tokyo). 1996 Dec;42(6):517-26.

75. Med Hypotheses. 1999 May;52(5):401-6.

76. Nippon Rinsho. 1999 Oct;57(10):2261-9.

77. J Am Coll Nutr. 1999 Feb;18(1):77-82.

78. Eur J Clin Nutr. 2005 Apr;59(4):592-6.

79. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.

80. Therosclerosis. 2003 May;168(1):169-79.

81. Diabetes Care. 2003 Apr;26(4):1147-52.

82. Eur J Nutr. 2007 Jun;46(4):230-7.

83. J Agric Food Chem. 2000;48:849-52.

84. Horm Metab Res. 2004 Feb;36(2):119-25.

85. Diabetes Care. 2003 (26):3215–8.

86. Diabetes Obes Metab. 2007 Nov;9(6):895-901.

87. Proc Nutr Soc. 2008 Feb;67(1):48-53.

88. Diabetes. 2005 Jul;54(7):1942-8.

89. J Med Chem. 1997 Jan 17;40(2):137-45.

90. Am J Clin Nutr. 2003 Oct;78(4):728-33.

91. Naunyn Schmiedebergs Arch Pharmacol. 2000 Aug;362(2):122-7.

92. Diabetes. 2005 Mar;54(3):765-9.

93. Clin Endocrinol (Oxf). 2006 Jan;64(1):46-52.

94. J Endocrinol. 1996 Sep;15(Suppl):S43-50.

95. Endocr J. 2005 Dec;52(6):727-33.

96. Clin Endocrinol (Oxf). 2005 Sep;63(3):239-50.

97. Atherosclerosis. 2005 Jul;181(1):159-65.

98. Med Clin (Barc). 2003 Nov 1;121(15):561-4.

99. Int J Cardiol. 1997 Aug 8;60(3):295-300.

100. Clin Sci (Lond). 2005 May;108(5):449-56.

101. Lancet. 2000 Feb 12;355(9203):517-22.

102. J Nephrol. 2003 Jul-Aug;16(4):522-34.

103. Metabolism. 2002 Jul;51(7):881-6.

104. Asia Pac J Clin Nutr. 2007 16(1):103-9.

105. Mol Genet Metab. 2006 Jul;88(3):201-7.

106. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):379-85.

107. J Nutr. 2007 Apr;137(4):1124.

108. J Nutr. 2000 Dec;130(12):3090-6.

109. Circulation. 1999 Mar 9;99(9):1156-60.

110. J Biol Chem. 2000 Jul 14;275(28):21177-84.

111. Arch Intern Med. 2004 Sep 13;164(16):1781-7.

112. Mayo Clin Proc. 2008 Mar;83(3):333-42.

113. Int J Cardiol. 2009 Feb 11.

114. Am Heart J. 2003 Feb;145(2):e8.

115. N Engl J Med. 2008 Nov 20;359(21):2195-207.

116. N Engl J Med. 1997 Apr 3;336(14):973-9.

117. Circulation. 1999 Aug 24;100(8):793-8.

118. Immunopharmacol Immunotoxicol. 2003 May;25(2):213-24.

119. JAMA. 2007 May 9;297(18):2018-24.

120. Free Radic Biol Med. 2009 Jan 1;46(1):70-7.

121. J Nutr. 2006 Jun;136(6):1517-21.

122. Biochem Pharmacol. 2005 Jan 15;69(2):241-8.

123. Biol Pharm Bull. 2002 Sep;25(9):1197-202.

124. J Pharmacol Exp Ther. 2001 Jan;296(1):181-7.

125. IUBMB Life. 2008 Jun;60(6):355-61.

126. J Rheumatol. 2008 Mar;35(3):407-13.

127. Am J Cardiol. 2001 Nov 15;88(10):1139-42.

128. Scand J Rheumatol. 1992;21(4):178-85.

129. J Nutr Sci Vitaminol (Tokyo). 1995 Apr;41(2):217-25.

130. Prostaglandins Leukot Essent Fatty Acids. 1998 Mar;58(3):185-91.

131. Clin Dev Immunol. 2004 Mar;11(1):13-21.

132. Int Immunopharmacol. 2001 Nov;1(12):2197-9.

133. Crit Care Med. 2004 Oct;32(10):2097-103.

134. Biochem Pharmacol. 2000 Feb 15;59(4):357-67.

135. Mediators Inflamm. 2006;5:30490.

136. Arch Pharm Res. 2002 Oct;25(5):561-71.

137. J Cell Biochem. 2004 Feb 1;91(2):232-42.

138. Am J Clin Nutr. 2004 Sep;80(3):649-55.

139. J Pharmacol Sci. 2008 Jun;107(2):128-37.

140. J Clin Endocrinol Metab. 2003 Oct;88(10):4623-32.

141. Arthritis Res. 1999;1:63-70.

142. QJM. 2002;95:787-96.

143. J Coll Physicians Surg Pak. 2004 Nov;14(11):673-6.

144. N Engl J Med. 2000 May 11;342(19):1392-8.

145. Int J Clin Pharmacol Ther Toxicol. 1990 Apr;28(4):153-7.

146. Atherosclerosis. 1982 Oct;45(1):1-10.

147. J Nutr. 2004 May;134(5):1181-5.

148. Mol Nutr Food Res. 2005 Jun;49(6):594-600.

149. Life Extension. 2008 Apr;14(3):37-43.

150. Proc Natl Acad Sci USA. 2002 Nov 26;99(24):15596-601.

151. J Endocrinol Invest. 2007 Jun;30(6):451-8.

152. Clin Endocrinol (Oxf). 2007 Mar;66(3):394-8.

153. Endocrinol Metab Clin North Am. 2007 Jun;36(2):365-77.

154. Arthritis Rheum. 2002 Nov;46(11):2924-7.

155. J Rheumatol. 1998 Feb;25(2):285-9.

156. World J Urol. 2003 Nov;21(5):346-55.

157. Compend Contin Educ Dent. 2004;Sep;25(9):681-2.

158. J Clin Periodontol. 2008 Apr;35(4):277-90.

159. Arch Intern Med. 2008 Jun 9;168(11):1174-80.

160. Arch Intern Med. 2008 Jun 23;168(12):1340-9.

161. Am J Clin Nutr. 1999 May;69(5):842-56.

162. Curr Osteoporos Rep. 2006 Sep;4(3):96-102.

163. http://healthnews.uc.edu/news/?/757/.

164. World J Gastroenterol. 2005 Nov 14;11(42):6722-4.

165. Pharmazie. 2005 Oct;60(10):765-71.

166. Thromb Haemost. 2004 Feb;91(2):373-80.

167. J Thromb Haemost. 2004 Dec;2(12):2118-32.

168. Thromb Haemost. 1998 Jun;79(6):1116-8.

169. Thromb Res. 2004;113(3-4):205-9.

170. Am J Health Syst Pharm. 2005 Aug 1;62(15):1574-81.

171. Atherosclerosis. 2008 Jul 19.

172. Blood. 2007 Apr 1;109(7):2823-31.

173. J Vasc Res. 2008;45(5):427-36.

174. J Nutr. 2004 Nov;134(11):3100-5.

175. J Bone Miner Metab. 2000 18(4):216-22.

176. J Thromb Haemost. 2007 Dec;5(12):2503-11.

177. Arch Intern Med. 2006 Jun 26;166(12):1256-61.

178. Vitam Horm. 2008;78:393-416.

179. Thromb Haemost. 2004;92(5):1018-24.

180. Blood. 2007 Apr 15;109(8):3279-83.

181. Nutrition. 2001 Apr;17(4):315-21.

182. Int J Epidemiol. 2000 Oct;29(5):832-6.

183. Circulation. 1998 Mar 24;97(11):1029-36.

184. Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K.

185. Neurology. 2008 Sep 30;71(14):1057-64.

186. J Am Geriatr Soc. 2006 Mar;54(3):413-20.

187. Stroke. 2008 Dec;39(12):3145-51.

188. JAMA. 2007 Jul 18;298(3):309-16.

189. JAMA. 2008 Nov 12;300(18):2142-52.

190. JAMA. 2007 Jul 18;298(3):299-308.

191. Am J Cardiol. 2008 Oct 15;102(8):1040-5.

192. Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):80-4.

193. Br J Clin Pharmacol. 2008 Sep 19.

194. J Agric Food Chem. 2005 Apr 6;53(7):2446-50.

195. Nutrition. 2005 Jul-Aug;21(7-8):848-54.

196. J Am Diet Assoc. 2005 Jan;105(1):65-71.

197. Altern Med Rev. 2004 Mar;9(1):63-9.

198. www.americanheart.org/presenter.jhtml?identifier=4632.

199. Am J Clin Nutr. 2000 Aug;72(2):389-94.

200. Am J Cardiol. 2000 Nov 1;86(9):943-9.

201. Expert Opin Pharmacother. 2008 May;9(7):1237-48.

202. Curr Cardiol Rep. 2003 Nov;5(6):470-6.

203. Br J Nutr. 2005 Apr;93(4):543-7.

204. Atherosclerosis. 2006 Apr;185(2):313-9.

205. J Nutr. 2002 Jul;132(7):1879-85.

206. J Nutr. 2005 Jun;135(6):1339-42.

207. J Am Coll Cardiol. 2005 Jul 5;46(1):120-4.

208. Am J Cardiol. 2007 Jan 15;99(2):154-8.

209. J Nutr Sci Vitaminol (Tokyo). 2003 Aug;49(4):270-6.

210. Lipids. 1998 Jun;33(6):567-72.

211. Biosci Biotechnol Biochem. 1995 Dec;59(12):2198-202.

212. Eur J Clin Nutr. 1993 Sep;47(Suppl 1):S85-90.

213. Neurology. 2007 Feb 20;68(8):563-8.

214. J Clin Endocrinol Metab. 2006 Nov;91(11):4433-7.

215. Neuro Endocrinol Lett. 2007 Apr;28(2):182-6.

216. Aging Male. 2004 Sep;7(3):197-204.

217. J Am Coll Cardiol. 2007 Sep 11;50(11):1070-6.

218. Biochem Biophys Res Commun. 2002 Sep 6;296(5):1051-7.

219. Handb Exp Pharmacol. 2005;170:537-61.

220. J Intern Med. 2008 Sep;264(3):245-53.

221. Menopause. 2006 Jul;13(4):643-50.

222. Eur J Cancer Prev. 2002 Aug;11(Suppl 2):S48-57.

223. Pharmacol Res. 2007 Aug;56(2):140-7.

224. J Steroid Biochem Mol Biol. 1993 Sep;46(3):381-8.

225. J Nutr. 1996 Apr;126(4):842-8.

226. Int J Obes. 1991 Nov;15(11):791-5.

227. Int J Impot Res. 2007 Sep;19(5):448-57.

228. Med Hypotheses. 1999 Jan;52(1):49-51.

229. Diabetes Care. 2007 Feb;30(2):318-24.

230. J Natl Cancer Inst. 2009 Jan 7;101(1):48-60.

231. N Engl J Med. 1998 Jul 23;339(4):229-34.

232. JAMA. 2002 Dec 4;288(21):2709-16.

233. Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):80-4.

234. N Engl J Med. 1996 Jan 25;334(4):269-70.

235. Eur J Clin Invest. 1998 Jun;28(6):441-6.

236. J Androl. 2009 Jan-Feb;30(1):23-32.

237. Gerontology. 2008;54(3):153-6.

238. Circ Res. 2000 Nov 10;87(10):840-4.

239. Arch Mal Coeur Vaiss. 2006 Oct;99(10):915-21.

240. Trends Neurosci. 2004 May;27(5):283-9.

241. Nitric Oxide. 2006 Nov;15(3):259-63.

242. Nitric Oxide. 2006 Sep;15(2):93-102.

243. Proc Natl Acad Sci USA. 2005 Mar 29;102(13):4896-901.

244. J Agric Food Chem. 2006 Mar 8;54(5):1928-35.

245. Drugs Exp Clin Res. 2002;28(2-3):49-62.

246. J Nutr. 2001 Aug;131(8):2082-9.

247. Br J Pharmacol. 2005 Jul;145(6):767-74.

248. J Nutr Biochem. 2005 Sep;16(9):570-6.

249. JAMA. 2003 Aug 27;290(8):1030-1.

250. Eur Ann Allergy Clin Immunol. 2007 Feb;39(2):45-50.

251. Curr Med Chem. 2008;15(18):1840-50.

252. Arch Biochem Biophys. 2008 Aug 15;476(2):102-6.

253. www.circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.108.191261.

254. Semin Thromb Hemost. 2002;28(Suppl 2):3-13.

255. Zhonghua Yi Xue Za Zhi. 2006 Mar 14;86(10):678-80.

256. Am Heart J. 2005 Apr;149(4):606-12.

257. N Engl J Med. 2000 Oct 19;343(16):1139-47.

258. N Engl J Med. 2000 Oct 19;343(16):1179-82.

259. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1734-40.

260. Circulation. 2003 Jul 15;108(2):155-60.

261. Am J Clin Nutr. 1996 Jan;63(1):116-22.

262. Am J Clin Nutr. 2006 Mar;83(3):567-74; quiz 726-7.

263. Nutrition. 2003 Mar;19(3):261-4.

264. Free Radic Res. 2006 Jan;40(1):85-94.

265. Drugs Exp Clin Res. 1978;4:49-53

266. Med Hypotheses. 1980;6(11):1123-33.

267. Clin Sci (Lond). 1994 Jan;86(1):43-8.

268. South Med J. 2008 Sep;101(9):918-24.

269. J Manag Care Pharm. 2007 Jun;13(5 Suppl):S3-5.

270. Am Heart J. 2006 Nov;152(5):867-75.

271. Hypertension. 2006 Feb;47(2):296-308.

272. JAMA. 2003 May 21;289(19):2560-72.

273. www.merck.com/product/usa/pi_circulars/c/cozaar/cozaar_pi.pdf.

274. www.benicar.com/pdf/prescribing_information.pdf.

275. Comp Biochem Physiol C. 1990;96(2):367-71.

276. Am J Hypertens. 2004 Nov;17(11 Pt 1):1056-8.

277. J Jpn Soc Nutr Food Sci. 1992;45:513-7.

278. Atherosclerosis. 2001 Sep;158(1):195-8.

279. Circulation. 1989;80(5):1320-7.

280. Eur J Public Health. 2004 Sept;14(3):235-9.

281. Epidemiology. 1992;3:194-202.

282. Lancet. 1999;354(9195):355-64.

283. Circulation. 1998;97:2222-9.

284. J Nutr. 2005 Nov;135(11):2739S-48S.

285. J Steroid Biochem Mol Biol. 2005 Jun;96(1):59-66.

286. N Engl J Med. 1989 Apr 20;320(16):1037-43.

287. Clin Exp Pharmacol Physiol. 1991 May;18(5):265-8.

288. Circulation. 1993 Aug;88(2):523-33.

289. Am J Clin Nutr. 1999 Nov;70(5):817-25.

290. Mol Aspects Med. 1994;15(Suppl):S265-72.

291. J Hum Hypertens. 1999 Mar;13(3):203-8.

292. Mol Aspects Med. 1994;15(Suppl):S257-63.

293. FASEB. 2006;20:A305.

294. Clin Sci (Lond). 2004 Nov;107(5):513-7.

295. Ann Pharmacother. 2008 Dec;42(12):1766-71.

296. Am J Clin Nutr. 1997;65(Suppl):712S-716S.

297. http://dashdiet.org/.

298. N Engl J Med. 2001 Jan 4;344(1):3-10.

299. Arch Fam Med. 1999 May-Jun;8(3):228-36.

300. J Cardiovasc Pharmacol. 2001 Oct;38(Suppl 1):S69-74.

301. Ann Intern Med. 2006 Apr 4;144(7):485-95.

302. Autoimmun Rev. 2008 Jul;7(7):558-66.

303. J Am Coll Cardiol. 1999 Oct;34(4):1208-15.

304. J Nutr. 2001 Feb;131(2):366S-8S.

305. Life Sci. 2000;66(2):161-71.

306. Nutrition. 2008 Oct;24(10):1030-8.

307. Antioxid Redox Signal. 2000;2(3):491-506.

308. Proc Natl Acad Sci USA. 1991 Mar 1;88(5):1646-50.

309. J Nutr. 2005b May;135(5):969-72.